It has been known for a number of years that high concentrations of vitamin C (ascorbic acid + dehydroascorbic acid) occur in some cells, but it is only recently that we have begun to discover how high the levels are and also that the vitamin seems to be secreted onto epithelial surfaces (Table 1 ). If we assume that such concentrations and secretions are needed for the appropriate biological activity of the vitamin, it follows that transport of vitamin C will be required in order to sustain normal metabolic functions. Further, if transport is central to the metabolism of vitamin C, any defect in the process could lead to the development of disease.
It has been known for a number of years that high concentrations of vitamin C (ascorbic acid + dehydroascorbic acid) occur in some cells, but it is only recently that we have begun to discover how high the levels are and also that the vitamin seems to be secreted onto epithelial surfaces (Table 1 ). If we assume that such concentrations and secretions are needed for the appropriate biological activity of the vitamin, it follows that transport of vitamin C will be required in order to sustain normal metabolic functions. Further, if transport is central to the metabolism of vitamin C, any defect in the process could lead to the development of disease. The study of transport mechanisms is, therefore, important in our understanding of vitamin C metabolism and this review will examine our present knowledge in this area and speculate on diseases that may impair these processes.
G E N E R A L C O N S I D E R A T I O N S A N D P R O B L E M S W I T H T H E S T U D Y OF VITAMIN C T R A N S P O R T
Any material which cannot be synthesized within the cell needs to be transported in two ways: across cell membranes and through biological fluids. Transport through biological (Rose, 1989; Washko et al. 1989) . Vitamin C can be filtered by the kidney (Basu & Schorah, 1982) and ultrafiltered from plasma suggesting that protein binding in the blood is minimal. [t is also rapidly lost from energy-depleted cells (Rose, 1988) indicating that binding within the cell is probably limited. On the other hand, Lovstad (1987) has shown that plasma protein can increase the stability of vitamin C. Whilst this could be explained by protein-binding of trace metals or free radicals, both of which tend to oxidize the vitamin, there is evidence of binding of ascorbic acid to serum albumin (Molloy & Wilson, 1980; Meucci et al. 1987) . It is also energy sparing to maintain the very high cell concentration of vitamin C with the assistance of protein binding rather than allowing the concentration to be expressed fully within the cell water. At the moment we can say no more than that vitamin C probably forms some associations with protein, such as albumin, which may, therefore, assist in its transport. The full significance of such associations and the strength of the binding remains to be determined. The polarity of ascorbic acid, which encourages its presence in aqueous fluids, also hinders its passage across the hydrophobic cell membrane (Rose, 1987) . This, and the high concentration within the cell, makes it almost certain that the vitamin will need carrier mechanisms to enter the cell. Because researchers have long been aware of this, there has been considerable investigation of the membrane transport of vitamin C. Unfortunately, our understanding of the mechanism remains restricted. This is because of the limitations of the techniques available and difficulties with the interpretation of much of the data. Problems caused by the use of different species, some requiring vitamin C in the diet and others not, and the use of unphysiological concentrations of vitamin C are being resolved. However, some major technical problems are only just beginning to be addressed.
When tissues slices or biopsies are used it is important to distinguish uptake into interstitial fluid from uptake into the cell (Raghoebar et al. 1987; Rose, 1989) . Even studies using isolated cells can fail to distinguish between membrane binding and actual cell uptake (Raghoebar et al. 1987) . This is particularly so where cells have been pulsed for short time intervals with isotopes of the vitamin (Mann & Newton, 1975) . Short incubations clearly have a disadvantage here, but have a considerable advantage when it comes to the much greater problem of vitamin C stability.
There are two compounds with biological activity, ascorbic acid and dehydroascorbic acid. Both are unstable, and whilst ascorbic acid is less reactive in some biological fluids, such as plasma, its half-life is short in tissue culture media and buffers that have been used in transport and cell uptake studies. Table 2 gives some indication of the rate of loss of total vitamin C (ascorbic acid + dehydroascorbic acid) and ascorbic acid from various fluids. Clearly, incubation in tissue culture medium quickly results in the production of breakdown products. The stability of the vitamin will depend on the mediumhuffer used, the type and presence of cells, the amount of oxygen in the gas phase and the initial concentration of ascorbic acid (Cullen et al. 1986; Padh & Aleo, 1987; Raghoebar et al. 1987 : Choi & Rose, 1989 Bergsten et al. 1990) . Reducing agents, such as glutathione, are able to stabilize vitamin C (Table 2) , but the high concentration needed is unphysiological and may affect transport of the vitamin. In addition, some reducing The medium was FWMI 1640 containing fetal calf serum (100 mU1) and antibiotics.
agents (dithiothreitol) can be cell toxic. The similarity of the results for total vitamin C and ascorbic acid in Table 2 probably reflect the even greater instability of dehydroascorbic acid at neutral pH, with reported half-lives of less than 30 min (Penney & Zilva, 1943; Bode et al. 1990) . It is, therefore, essential that for in vitro studies there is an attempt to measure which metabolite is concentrated into the cell. Unfortunately, many studies that have used [14C]ascorbic acid have only assessed cell uptake of total radioactivity and no attempt has been made to ascertain in what form that radioactivity is present. The final problem concerns potential losses of the vitamin during cell isolation and separation. It has been shown recently that different isolation procedures produce different levels of the vitamin associated with the cell (Bowers-Komro & McCormick, 1991) . The technique which results in the lowest values has been considered the poorer as it has been assumed that loss has occurred from within the cell. This, however, may not be the case as increased washing may remove non-specific membrane binding of the vitamin and, therefore, give a more accurate measure of the true intracellular level.
These problems make the interpretation of many studies of vitamin C membrane transport in isolated cells and tissues difficult. However, it is possible to draw some conclusions from studies where attempts have been made to measure the concentrations of ascorbic acid and its metabolites.
MECHANISMS OF VITAMIN C TRANSPORT
Because ascorbic acid and dehydroascorbic acid both have vitamin C-like activity it is necessary to consider the transport of both components. Tables 3 and 4 attempt to summarize the most reliable findings for the transport of ascorbic acid. Only the placental and leucocyte studies (neutrophil, mononuclear cells) have been undertaken in man. The concentration of the vitamin within the cells studied, its poor membrane permeability (Rose, 1987) and the need for energy make it almost certain that the form of transport of ascorbic acid is facilitated, i.e. requiring a membrane carrier, and active. 11 Padh & Ale0 (1987) , Wilson & Dixon (1989b) . 
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In the majority of cells studied the process also seems to be dependent on extracellular sodium. The presence of Na seems to decrease the Michaelis constant (Km) and, therefore, increase the affinity of the vitamin for its membrane carrier protein rather than changing the maximum velocity Vma; (Diliberto et al. 1983; Padh & Aleo, 1987; Wilson & Dixon, 1989b) . There is also some evidence that divalent metal ions, such as calcium, may also stimulate ascorbate transport (Padh & Aleo, 1987; Garcia & Municio, 1990; Washko et al. 1990 ).
The specificity of the process is less well understood. There are only a limited number of studies which have looked at the ability of analogues of ascorbic acid to either inhibit uptake, when on the same side of the membrane, or stimulate transport, when on the opposite side (so called cis-inhibition-trans-stimulation). Published reports indicate that the process seems to be fairly specific to ascorbic acid with pre-incubation in the absence of the vitamin enhancing uptake (Wilson et al. 1990 ). There is still controversy as to whether glucose is able to compete with ascorbic acid transport and, therefore, inhibit its uptake. This will be considered further in relation to the impact of disease on the transport of vitamin C.
Most cells seem to be able to transport dehydroascorbic acid, the oxidized form of the vitamin (Stankova et al. 1975 (Stankova et al. , 1984 Bigley et al. 1983; Cullen et al. 1986; Rose, 1987 Rose, , 1989 Choi & Rose, 1989; Helbig et al. 1990; Rose & Choi, 1990) . Usually the process is facilitated diffusion, i.e. with a carrier, but not against an electrochemical gradient or requiring energy. Glucose may well inhibit the process. Net uptake of dehydroascorbate is probably maintained by the ability of cells to rapidly reduce it to ascorbic acid and, thus, maintain a low intracellular concentration of the oxidized form of the vitamin. It is possible that co-transport of ascorbic acid by this system provides an additional mechanism for moving ascorbic acid across cell membranes.
Two special situations need to be considered. Kidney tubules, intestinal mucosa and possibly the ciliary epithelium of the eye transport vitamin C across the cell (Table 4) . Uptake of ascorbic acid from tubular fluid, intestinal lumen and plasma respectively seems to be the process described previously, i.e. facilitated, active and requiring Na. Once in the cell, passage down the concentration gradient into the blood, or in the case of the eye, the aqueous humour, is facilitated diffusion and this mechanism may also transport dehydroascorbic acid, but usually in the opposite direction, into the cell. Finally, there is evidence that white cells, such as neutrophils and mononuclear cells, have a different transport mechanism for vitamin C (Table 3 ). The process is active, but does not seem to be dependent on Na and is susceptible to inhibition by glucose. There is also evidence that the transport of dehydroascorbic acid is preferred (Stankova et al. 1975; Bigley et al. 1983; Davis et al. 1983; Moser & Weber, 1984; Raghoebar et al. 1987; Washko et al. 1989 Washko et al. ,1990 . However, there is a hypothesis which could account for these apparent differences without the need to propose a separate mechanism. Ascorbic acid is at risk of rapid oxidation close to the membrane of the neutrophil or the macrophage because of the reactive species generated by these cells as part of their immune function (Rossi et al. 1985) . Because of the rapid generation of dehydroascorbic acid on the cell membrane, uptake of vitamin C may be predominantly in the oxidized form by the system of facilitated diffusion present in other cells with rapid reduction of dehydroascorbic acid within the cell maintaining a net inward flow. These cells will still actively transport ascorbic acid and the apparent inhibition of this process by glucose, and the lack of a requirement for Na (not found in other cells), could be an artifact created by the incubation conditions leading rapidly to the generation of dehydroascorbic acid, the subsequent transport of which is affected by glucose and does not require Na.
IMPACT OF DISEASE ON TRANSPORT OF VITAMIN C
There are a number of conditions where low vitamin C concentrations have been reported in body fluids or in cell compartments and where these decreases cannot be explained entirely by a reduction in intake. Severe infection and other acute diseases have long been associated with low vitamin C levels in plasma and leucocytes (Basu & Schorah, 1982) . Smoking is known to decrease vitamin C intake, but a number of studies have shown that levels in both plasma and leucocytes cannot be explained wholly by intake (Pelletier, 1975; Kallner et al. 1981; Schectman et al. 1989) . Both situations will lead to some increase in reactive species generation and this will automatically lead to an increased turnover of ascorbic acid through oxidation (Cochrane et al. 1983; Anderson 1988; Frei et al. 1989) . It is also possible that severe infection will, as part of the acute-phase response, lead to both a redistribution of vitamin C from the plasma compartment into interstitial fluid and a change in the proportion of the vitamin C-containing leucocytes (Schorah et al. 1986) . It remains to be seen whether vitamin C transport is also impaired in these situations.
Reports of decreased levels in the eye following cataract formation (Bron & Brown, 1987) require more study to determine if transport problems are involved in the change.
The recent findings that vitamin C is found in high concentrations in gastric juice (Sobala et al. 1989; Schorah et al. 1991) and may well be secreted onto other epithelial surfaces (Paterson & O'Rourke, 1987; Patriarca et al. 1991) , raises the possibility of it acting as a general antioxidant in these situations. Gastric juice is particularly interesting, because its normally high concentrations are considerably reduced by the presence of chronic gastritis, a cellular inflammatory response, but not by reflux chemical gastritis where there is little invasion of the gastric mucosa by leucocytes ( Table 5) . We have recently shown that, in patients with gastritis, oral vitamin C supplements were unable to restore gastric juice vitamin C, although plasma concentrations were increased significantly by this treatment (Table 6 ). We do not know why gastritis lowers gastric juice vitamin C. It may well represent a paralysis or poisoning of the transport system for ascorbic acid. An alternative explanation would be that ascorbic acid secretion continues normally but the leucocyte infiltration and associated free radical generation converts most of it to dehydroascorbic acid which is then rapidly re-absorbed. Destruction of the dehydroascorbic acid to products without vitamin C activity is unlikely as patients with gastritis do not develop clinical scurvy. More work is required because it is possible that vitamin C has important protective functions within gastric juice and its near absence in conditions such as chronic gastritis could contribute to the increased risk of gastric cancer seen in this group of patients .
One of the most contentious situations where vitamin transport may be affected by disease is in diabetes. The hypothesis is developed in this way. Diabetes encourages low glucose levels in some cells and this reduces the activity of the pentose-phosphate pathway leading to decreased cell NADPH and reduced glutathione which in turn impairs the reduction of dehydroascorbic acid to ascorbic acid. Glucose and dehydroascorbic acid compete for transport across cell membranes and the increased blood glucose in diabetics, along with the impaired ability to reduce dehydroascorbic acid in the cell, could reduce cell uptake of dehydroascorbic acid. The result of this is to increase plasma dehydroascorbic acid levels and to decrease cell ascorbic acid concentrations. This could encourage diabetic complications by allowing oxidation of cell membranes and impairment of connective tissue production (Mann & Newton, 1975) . Not all the evidence, however, supports the hypothesis. Uptake of glucose and dehydroascorbic acid into some cells seems to be impaired in the diabetic and this may also extend to uptake of ascorbic acid (Chen et al. 1983; Davis et al. 1983; Kapeghian & Verlangieri, 1984; Stankova et al. 1984; McLennan et al. 1988) . Reports published some years ago also suggested that there was indeed accumulation of dehydroascorbic acid in plasma (Chatterjee et al. 1975; Chatterjee & Banerjee, 1979; Som et al. 1981; Banerjee, 1982) . Unfortunately, there is reason to believe that technical problems have made these earlier studies unsound and more recent work has been unable to confirm these increases in dehydroascorbic acid (Newill et al. 1984; Stankova et al. 1984; Sinclair et al. 1991) . Some publications have suggested a decrease in plasma vitamin C concentrations in diabetes but this has not been confirmed by other groups. The most recent studies, and those that have attempted to match for intake, suggest little change in the plasma levels of vitamin C. (Bryszawska & Kostrzewa, 1987; Schorah et al. 1988; Cunningham et al. 1991) . Studies that have investigated changes in cellular vitamin C are more consistent in finding a decrease (Chen et al. 1983; Bryszawska & Kostrzewa, 1987; Cunningham et al. 1991) with only one finding little change (Schorah et al. 1988) . What can we make of all this? It seems clear that dehydroascorbic acid uptake can be impaired by increased glucose levels and that this may lead to some decrease in the vitamin C concentration in some cells (especially leucocytes). In contrast, there appears to be little change in plasma ascorbic acid or dehydroascorbic acid concentrations. Whether the decrease in the cell levels is sufficient to produce an effect on cell metabolism and encourage some diabetic complications remains to be investigated. The situation does appear to represent one of the most likely examples of a direct effect of disease on vitamin C transport.
C O N C L U S I O N S
Because of the technical problems found in studies of vitamin C transport it is difficult to draw firm conclusions. It is clear that vitamin C is concentrated into a number of cell types, sometimes to very high levels, and that this must require expenditure of cell energy. The limited cell membrane permeability of vitamin C means that transport must also be facilitated. The process in most cells seems to require Na and prefer ascorbic acid. There is some evidence that dehydroascorbic acid is transported by a separate mechanism which can also co-transport ascorbic acid and which uses facilitated diffusion. It is also possible that leucocytes have a different mechanism from other cells for the transport of ascorbic acid, but the findings can be explained by the tendency of these cells to produce reactive species which could rapidly oxidize ascorbic acid to dehydroascorbic acid encouraging this to be the form usually transported.
There are a number of diseases which may affect vitamin C transport. The most likely candidates are diabetes, as a result of disturbed cell or plasma glucose distribution, and damage, by a cellular inflammatory response or poisons, to mucosal surfaces which secrete vitamin C. The area is ripe for further investigation, but researchers must be careful to determine which component or metabolite of the vitamin is being transported.
